NCT07069712 2026-03-10
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
AstraZeneca
Phase 2 Recruiting
AstraZeneca
AstraZeneca
Samsung Medical Center
AstraZeneca
University of Southampton